Cargando…

Sars-Cov-2 and risk of antiviral drug resistance

Detalles Bibliográficos
Autor principal: Vitiello, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554178/
https://www.ncbi.nlm.nih.gov/pubmed/34714491
http://dx.doi.org/10.1007/s11845-021-02820-y
_version_ 1784591738711572480
author Vitiello, Antonio
author_facet Vitiello, Antonio
author_sort Vitiello, Antonio
collection PubMed
description
format Online
Article
Text
id pubmed-8554178
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85541782021-10-29 Sars-Cov-2 and risk of antiviral drug resistance Vitiello, Antonio Ir J Med Sci Letter to the Editor Springer International Publishing 2021-10-29 2022 /pmc/articles/PMC8554178/ /pubmed/34714491 http://dx.doi.org/10.1007/s11845-021-02820-y Text en © The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Vitiello, Antonio
Sars-Cov-2 and risk of antiviral drug resistance
title Sars-Cov-2 and risk of antiviral drug resistance
title_full Sars-Cov-2 and risk of antiviral drug resistance
title_fullStr Sars-Cov-2 and risk of antiviral drug resistance
title_full_unstemmed Sars-Cov-2 and risk of antiviral drug resistance
title_short Sars-Cov-2 and risk of antiviral drug resistance
title_sort sars-cov-2 and risk of antiviral drug resistance
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554178/
https://www.ncbi.nlm.nih.gov/pubmed/34714491
http://dx.doi.org/10.1007/s11845-021-02820-y
work_keys_str_mv AT vitielloantonio sarscov2andriskofantiviraldrugresistance